News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Cavit Sciences, Inc. Announces Asset Purchase Agreement
May 29, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOCA RATON, FL--(Marketwire - May 30, 2008) - Cavit Sciences, Inc. ("Cavit") (OTCBB: CVIT) announced today that it completed an Asset Purchase Agreement with Alternecare Health Products, Inc. ("Alternecare™") on May 28, 2008.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Business
Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raft
November 2, 2026
·
3 min read
·
Angela Gabriel
Cell therapy
Cell therapy investment grows as safety events rankle Big Pharma’s CAR T autoimmune push
November 2, 2026
·
3 min read
·
Annalee Armstrong
Earnings
AbbVie’s Q3 beat should keep ‘train rolling’ as company eyes bolt-on deals
October 30, 2026
·
3 min read
·
Gabrielle Masson
Earnings
AstraZeneca employs $1.5B cost savings to reinvest back into growth
October 30, 2026
·
3 min read
·
Annalee Armstrong
